Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03535818

Adjunctive Ganglionated Plexus Ablation in Redo-Pulmonary Vein Isolation

Adjunctive GP Ablation In Redo-PVI: Paroxysmal Atrial Arrhythmias After Pulmonary Vein Isolation Are Driven By Ectopy-Triggering Left Atrial Ganglionated Plexus

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

The investigator propose to test the efficacy of adjunctive ET-GP ablation in patients undergoing redo PVI for paroxysmal AF.

Detailed description

Patients with ongoing paroxysmal arrhythmias after pulmonary vein isolation (PVI) for paroxysmal and persistent atrial fibrillation (AF) get incrementally less benefit with redo-PVI. This implies non-pulmonary vein (PV) triggers, which are more challenging to locate. The autonomic nervous system is implicated in the multifactorial pathogenesis of AF but few studies have attempted neural targeting as a therapeutic intervention. We have demonstrated that stimulation of specific left atrial ganglionated plexi (GPs) triggers both AF and atrial ectopy and importantly stimulation of these sites may not induce AV block, the 'conventional' marker used to locate GPs. Having shown that these ectopy-triggering GP (ET-GP) sites are anatomically stable and can be rendered inactive by either ablation at the site or by ablation between the site and the adjacent PV, a single centre study suggests that ET-GP ablation can prevent recurrent AF in some patients.

Conditions

Interventions

TypeNameDescription
PROCEDURERadiofrequency ablationRF application to achieve complete pulmonary vein isolation +/- ganglionated plexus ablation

Timeline

Start date
2017-06-14
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2018-05-24
Last updated
2024-08-09

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03535818. Inclusion in this directory is not an endorsement.